Hydrophilic Polymers Exhibit Boundless Opportunities for Multiple Fields

Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Needs

Creative Biogene Introduces One-Stop Microbial Genome Editing Services

BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity

PseudoUridine Phosphoramidites for Efficient and Reliable Syntheses of RNA Oligonucleotides

learwater and CynergisTek Complete Merger, Bringing Together Cybersecurity, Privacy, and Compliance Leaders

Clearwater announced today that its planned merger with CynergisTek has been completed, bringing together two market leaders who are joining forces to serve the cybersecurity, privacy, and compliance needs of healthcare organizations, as well as those in other highly regulated industries. As a result of the transaction, CynergisTek is now a privately owned company and will operate as a subsidiary of Clearwater, aside Clearwater’s recently acquired TECH LOCK Division. Common mission, values, and customer focus among all three companies provide a strong foundation to create a clear market leader in healthcare cybersecurity and compliance.

New PALSAR Method Now Available for Bioanalysis of Oligonucleotides and Other Intermediate Molecules

SEKISUI announces their newest bioanalytical method, PALSAR, which is a proprietary hybridization method for the measurement of oligonucleotides, ADCs and other intermediate molecules.

Laverock Therapeutics founded to develop the next generation of programmable cell therapies

Curebase Names Digital Infrastructure Veteran Matt Lanier as VP of Engineering

Curebase, a company committed to democratizing access to clinical studies, has named veteran digital infrastructure executive Matt Lanier as vice president of engineering.

Cotiviti to Share Strategies for Risk Adjustment Excellence at RISE West 2022 Conference

Cotiviti and health plan executives will discuss how to intelligently drive member interventions and achieve premium accuracy

PubHive Wins Award for Best Integrated Pharmacovigilance (PV) Literature & Aggregate Safety Reporting Solution

Cloud software platform PubHive Navigator earns ‘Best Integrated Pharmacovigilance Literature & Aggregate Safety Reporting Solutions’ award from Global Health & Pharma Magazine

Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox

Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software to Expand Access to Precision Oncology Biomarker Testing

Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, lengthy turnaround times can limit the clinical utility of these results. To meet the need for rapid genomic insights, Thermo Fisher Scientific today launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor

ZeOmega Recognized in KLAS Research CMS Payer Interoperability 2022 Vendor Guide

ZeOmega®, the leading population health management organization, today announced that it is featured in the KLAS Research CMS Payer Interoperability 2022 Vendor Guide. The report lists ZeOmega as one of the top performing companies whose solutions help payers comply with regulations for secure data exchange.

Rho Announces Findings from Study it Coordinated to Explore Therapy for Reducing Asthma Attacks Among Disadvantaged Urban Youth

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.

MMS Announces Key Executive Appointment to Support Company's Next Stage of Growth

MMS Holdings, a data-focused contract research organization, announced the appointment of Kelly J. Hill to Chief Strategy Officer. This announcement comes as the company is accelerating in growth after its partnership with a private equity firm.

Lifeasible Helps Resolve Insect and Mollusc Genome Detection Issues

Matexcel Enlarged Its Raw Materials Offerings for Bone Implants